Citadel Advisors
KOD icon

Citadel Advisors’s Kodiak Sciences KOD Stock Holding History

Citadel Advisors’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.14M Sell
157,524
-713,264
-82% -$27.8M ﹤0.01% 4377
2026
Q1 		$33.2M Buy
870,788
+580,309
+200% +$15M 0.01% 1753
2025
Q4 		$8.12M Buy
290,479
+245,024
+539% +$5.02M ﹤0.01% 3533
2025
Q3 		$744K Buy
+45,455
New +$392K ﹤0.01% 8198
2024
Q4 		– Sell
-169
Closed -$972 – 14973
2024
Q3 		$441 Buy
+169
New +$449 ﹤0.01% 14018
2024
Q2 		– Sell
-2,128
Closed -$7.21K – 14907
2024
Q1 		$11.2K Sell
2,128
-52,715
-96% -$258K ﹤0.01% 13424
2023
Q4 		$167K Sell
54,843
-370,022
-87% -$823K ﹤0.01% 10229
2023
Q3 		$765K Buy
424,865
+61,784
+17% +$218K ﹤0.01% 7153
2023
Q2 		$2.51M Sell
363,081
-528,017
-59% -$3.23M ﹤0.01% 4761
2023
Q1 		$5.52M Buy
891,098
+581,311
+188% +$4.07M ﹤0.01% 3643
2022
Q4 		$2.22M Buy
309,787
+86,278
+39% +$619K ﹤0.01% 5281
2022
Q3 		$1.73M Buy
223,509
+100,752
+82% +$979K ﹤0.01% 5862
2022
Q2 		$938K Sell
122,757
-116,911
-49% -$821K ﹤0.01% 7170
2022
Q1 		$1.85M Buy
239,668
+138,660
+137% +$5.41M ﹤0.01% 6252
2021
Q4 		$8.56M Buy
101,008
+30,325
+43% +$3.09M ﹤0.01% 3329
2021
Q3 		$6.78M Sell
70,683
-21,759
-24% -$2.01M ﹤0.01% 3739
2021
Q2 		$8.6M Sell
92,442
-33,086
-26% -$3.18M ﹤0.01% 3340
2021
Q1 		$14.2M Buy
125,528
+97,153
+342% +$13.3M ﹤0.01% 2448
2020
Q4 		$4.17M Sell
28,375
-12,115
-30% -$1.35M ﹤0.01% 3979
2020
Q3 		$2.4M Buy
40,490
+10,178
+34% +$511K ﹤0.01% 4394
2020
Q2 		$1.64M Sell
30,312
-67,089
-69% -$3.78M ﹤0.01% 4914
2020
Q1 		$4.65M Buy
+97,401
New +$5.84M ﹤0.01% 2819
2019
Q3 		– Sell
-14,016
Closed -$164K – 9501
2019
Q2 		$164K Buy
+14,016
New +$125K ﹤0.01% 8315

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Braidwell
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Boxer Capital Management
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Citadel Advisors's KOD Position: Q2 2026 in Review

Citadel Advisors reduced its Kodiak Sciences (KOD) stake by 82% in Q2 2026, selling an estimated $27.8M and leaving 157,524 shares worth $6.14M. The position accounts for ﹤0.01% of the portfolio, ranked #4377.

Citadel Advisors first reported a position in KOD in Q2 2019 and has held it in 23 quarters since. The position peaked at $33.2M in Q1 2026. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • Citadel Advisors held 157,524 shares of Kodiak Sciences worth $6.14M as of Q2 2026.
  • Citadel Advisors sold 713,264 Kodiak Sciences shares in Q2 2026, an estimated $27.8M.
  • Kodiak Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4377 holding.
  • Citadel Advisors first reported a position in Kodiak Sciences in Q2 2019 and has held it in 23 quarters since.
  • Citadel Advisors's Kodiak Sciences position peaked at $33.2M in Q1 2026.
  • 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.